William Gallivan, MD
Orthopaedic Surgery · Santa Barbara, CANPI 1790702777
Payments from drug & device makers
Across 167 payments — averaging $606.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lazurite Inc.$81K
- Stryker$12K
- Smith+Nephew$2K
- Arthrex$2K
- Encore Medical, LP$1K
- Cornerstone Medical Associates, Inc.$888
- plus $2K from 16 others
What the payments were for
- Travel & lodging$11,54058%
- Food & beverage$8,45342%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lazurite Inc. | 4 | $81,263 |
| Stryker | 86 | $12,007 |
| Smith+Nephew | 19 | $2,351 |
| Arthrex | 19 | $1,585 |
| Encore Medical, LP | 4 | $1,437 |
| Cornerstone Medical Associates, Inc. | 6 | $888 |
| Heron Therapeutics, Inc. | 2 | $224 |
| Orthosensor Inc. | 3 | $201 |
| Illuminoss Medical, Inc. | 2 | $198 |
| Medacta USA, Inc. | 3 | $188 |
| KCI USA, Inc. | 2 | $138 |
| Nuvasive Specialized Orthopedics, Inc. | 1 | $116 |
| Zimmer Biomet | 1 | $116 |
| Vericel Corporation | 1 | $103 |
| Radius Health, Inc. | 1 | $100 |
| Bioventus LLC | 3 | $74 |
| Johnson & Johnson(2 entities) | 2 | $66 |
| Alphatec Spine, Inc | 1 | $56 |
| Omnilife Science, Inc | 1 | $55 |
| Davol Inc. | 2 | $40 |
| Electronic Waveform Lab, Inc. | 3 | $32 |
| Heraeus Medical, LLC. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$8,284
- DJO SURGICAL$1,437
- NAVIO$1,013
- BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION$890
- CORI$626
- PROFYLE$347
- PANGEA$330
- Navio Surgical System$225
- JOURNEY II UK$224
- Journey Uni$224
- Zynrelef$224
- AEQUALIS PERFORM REVERSED$166
- Verasense$154
- ARTHREX$145
- TRIGEN InterTAN$139
- VAC VERAFLO CLEANSE CHOICE$124
- PREVENA$124
- AXSOS$123
- PRECICE Intramedullary Limb Lengthening System$116
- MOTIONSENSE DIGITAL GONIOMETER$116
How this compares
$101,256 in reported general payments places this provider in the 90th percentile of 1,808 orthopaedic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 124 | $6,568 |
| Doxycycline Hyclate | 48 | $543 |
| Mupirocin | 65 | $434 |
| Pregabalin | 40 | $411 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 40 | $351 |
| Amoxicillin | 125 | $217 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 18 | $214 |
| Cefadroxil | 16 | $141 |
| Ondansetron OdtOndansetron | 18 | $126 |
| Tramadol Hcl | 60 | $125 |
| Cephalexin | 22 | $84 |
| Meloxicam | 22 | $65 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Santa Barbara
- Christopher ProctorSanta Barbara$1.1M
- Bradford HackArcadia$18.3M
- Robert GorabOrange$14.5M
- Kelly VinceLos Angeles$9.6M
- Stephen HowellSacramento$9.4M
- Thomas CoonRed Bluff$9.2M
- Peter NewtonSan Diego$7M
- Nirav AminPlacentia$5.8M
- Tom NorrisSan Francisco$5.3M
- Jay LiebermanLos Angeles$4.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.